Sind Antioxidantien zur Behandlung der Atherosklerose sinnvoll?

Zusammenfassung

Die Ergebnisse experimenteller und epidemiologischer Studien legen nahe, dass dem oxidativen Stress in der Entstehung und Progression der Atherosklerose im Menschen eine wichtige Bedeutung zukommt. Diese konnte in prospektiven Endpunktstudien bislang nicht nachgewiesen werden. In der vorliegenden Übersicht wird der aktuelle Stand der Literatur zusammenfasst.

Summary

Results from experimental and epidemiologic studies suggest an influence of oxidative stress on development and progression of atherosclerosis in man. Prospective endpoint studies failed to support this hypothesis. The current literature is summarized in this review.

Literatur

• 1 Routine vitamin supplementation to prevent cancer and cardiovascular disease . Recommendations and rationale.  Ann Intern Med. 2003;  139 51-55
• 2 Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A. et al . Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.  Lancet. 2000;  356 1213-1218
• 3 Brasen J H, Koenig K, Bach H, Kontush A, Heinle H, Witting P K. et al . Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.  Atherosclerosis. 2002;  163 249-259
• 4 Brigelius-Flohe R, Kelly F J, Salonen J T, Neuzil J, Zingg J M, Azzi A. The European perspective on vitamin E: current knowledge and future research.  Am J Clin Nutr. 2002;  76 703-716
• 5 Brown B G, Cheung M C, Lee A C, Zhao X Q, Chait A. Antioxidant vitamins and lipid therapy: end of a long romance?.  Arterioscler Thromb Vasc Biol. 2002;  22 1535-1546
• 6 de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.  Lancet. 2001;  357 89-95
• 7 de Lorgeril M, Salen P, Martin J L, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.  Circulation. 1999;  99 779-785
• 8 Diaz M N, Frei B, Vita J A, Keaney J F. Antioxidants and atherosclerotic heart disease.  N Engl J Med. 1997;  337 408-416
• 9 Drexler H. Endothelfunktion bei kardiovaskulären Erkrankungen. UNI-MED Verlag Bremen 2000
• 10 Fayad Z A, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts.  Circulation. 2002;  106 2026-2034
• 11 Frei B. To C or not to C, that is the question!.  J Am Coll Cardiol. 2003;  42 253-255
• 12 Gaytan R J, Prisant L M. Oral nutritional supplements and heart disease: a review.  Am J Ther. 2001;  8 255-274
• 13 GISSI-Study group . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico.  Lancet. 1999;  354 447-455
• 14 Harris A, Devaraj S, Jialal I. Oxidative Stress, Alpha-tocopherol Therapy, and Atherosclerosis.  Curr Atheroscler Rep. 2002;  4 373-380
• 15 Hein H O, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study.  BMJ. 1996;  312 736-741
• 16 Heinecke J W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.  Arterioscler Thromb Vasc Biol. 2001;  21 1261-1264
• 17 Heinecke J W. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis.  Am J Cardiol. 2003;  91 12A-16A
• 18 Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.  Circulation. 2001;  104 2673-2678
• 19 Hennekens C H, Buring J E, Manson J E, Stampfer M, Rosner B, Cook N R. et al . Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.  N Engl J Med. 1996;  334 1145-1149
• 20 Hornig B. Vitamins, antioxidants and endothelial function in coronary artery disease.  Cardiovasc Drugs Ther. 2002;  16 401-409
• 21 HPS-Study Group . MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.  Lancet. 2002;  360 23-33
• 22 Jialal I, Devaraj S. Antioxidants and atherosclerosis: don’t throw out the baby with the bath water.  Circulation. 2003;  107 926-928
• 23 Keaney J F, Vita J A. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action.  Prog Cardiovasc Dis. 1995;  38 129-154
• 24 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study.  BMJ. 1996;  312 478-481
• 25 Libby P. Vascular biology of atherosclerosis: overview and state of the art.  Am J Cardiol. 2003;  91 3A-6A
• 26 Littarru G P. Energie und Schutz. Casa Editrice Scientifica Internazionale, Rom 1994
• 27 Morris C D, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force.  Ann Intern Med. 2003;  139 56-70
• 28 Osganian S K, Stampfer M J, Rimm E, Spiegelman D, Hu F B, Manson J E. et al . Vitamin C and risk of coronary heart disease in women.  J Am Coll Cardiol. 2003;  42 246-252
• 29 Rapola J M, Virtamo J, Ripatti S, Huttunen J K, Albanes D, Taylor P R. et al . Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.  Lancet. 1997;  349 1715-1720
• 30 Rimm E B, Stampfer M J, Ascherio A, Giovannucci E, Colditz G A, Willett W C. Vitamin E consumption and the risk of coronary heart disease in men.  N Engl J Med. 1993;  328 1450-1456
• 31 Salonen R M, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen T H. et al . Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study.  Circulation. 2003;  107 947-953
• 32 Schroeder S, Kopp A F, Baumbach A, Meisner C, Kuettner A, Georg C. et al . Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography.  J Am Coll Cardiol. 2001;  37 1430-1435
• 33 Stampfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B, Willett W C. Vitamin E consumption and the risk of coronary disease in women.  N Engl J Med. 1993;  328 1444-1449
• 34 Steinberg D, Witztum J L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?.  Circulation. 2002;  105 2107-2111
• 35 Stephens N G, Parsons A, Schofield P M, Kelly F, Cheeseman K, Mitchinson M J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS).  Lancet. 1996;  347 781-786
• 36 Terentis A C, Thomas S R, Burr J A, Liebler D C, Stocker R. Vitamin E oxidation in human atherosclerotic lesions.  Circ Res. 2002;  90 333-339
• 37 Thomas S R, Leichtweis S B, Pettersson K, Croft K D, Mori T A, Brown A J. et al . Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice.  Arterioscler Thromb Vasc Biol. 2001;  21 585-593
• 38 U.S.Preventive Task Force . Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.  Ann Intern Med. 2003;  139 51-55
• 39 Virtamo J, Rapola J M, Ripatti S, Heinonen O P, Taylor P R, Albanes D. et al . Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease.  Arch Intern Med. 1998;  158 668-675
• 40 Wasserman M A, Sundell C L, Kunsch C, Edwards D, Meng C Q, Medford R M. Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease.  Am J Cardiol. 2003;  91 34A-40A
• 41 Willett W C, Stampfer M J. Clinical practice. What vitamins should I be taking, doctor?.  N Engl J Med. 2001;  345 1819-1824
• 42 Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.  N Engl J Med. 2000;  342 154-160